Drug Profile
Tilactase - Pro Farma
Alternative Names: Beta-D-galactosidase; LacdigestLatest Information Update: 02 Sep 2016
Price :
$50
*
At a glance
- Originator Pro Farma
- Developer MN Pharmaceuticals; Recordati
- Class Galactosidases
- Mechanism of Action Enzyme replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Lactose intolerance
Most Recent Events
- 10 Jul 2009 Launched for Lactose intolerance in Turkey (PO) after July 2009
- 10 Jun 2009 Registered for Lactose intolerance in Turkey (PO) (MN Pharmaceuticals website, August 2016)
- 31 Mar 2009 Launched for Lactose intolerance in Italy (PO) after March 2009